Has results × Erlotinib Hydrochloride × Gastrointestinal × Clear all Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
Phase 3 Completed
546 enrolled 29 charts
Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer
Phase 2 Terminated
16 enrolled 4 charts
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
Phase 2 Completed
673 enrolled 22 charts
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
Phase 1/2 Completed
25 enrolled 10 charts
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
Phase 2 Completed
45 enrolled 7 charts
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Phase 2 Completed
46 enrolled 13 charts
Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
Phase 2 Completed
62 enrolled 8 charts
S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Phase 1/2 Completed
134 enrolled 12 charts
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
Phase 1/2 Terminated
5 enrolled 9 charts
Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia
Phase 2 Completed
38 enrolled 14 charts
Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
20 enrolled 11 charts
MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic Cancer
Phase 1/2 Completed
81 enrolled 19 charts
Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Phase 2 Completed
46 enrolled 13 charts
ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA)
Phase 2 Completed
48 enrolled 11 charts
Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery
Phase 2 Terminated
7 enrolled 9 charts
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Phase 2 Completed
123 enrolled 10 charts
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Phase 2 Completed
28 enrolled 11 charts
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer
Phase 2 Terminated
249 enrolled 4 charts
An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Completed
338 enrolled 18 charts
Gem-ox
Phase 2 Terminated
33 enrolled 9 charts
Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine
Phase 2 Completed
36 enrolled 10 charts
Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Phase 2 Completed
30 enrolled 7 charts
Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
Phase 2 Completed
95 enrolled 12 charts
7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer Patients
Phase 2 Terminated
6 enrolled 3 charts
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
Phase 2 Completed
32 enrolled 12 charts
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
Phase 1/2 Completed
32 enrolled 14 charts
Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
104 enrolled 10 charts
A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
Phase 3 Completed
80 enrolled 10 charts
Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
Phase 1 Completed
27 enrolled 6 charts
A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma
Phase 2 Terminated
1 enrolled 4 charts
Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Phase 2 Terminated
18 enrolled 6 charts
A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer
Phase 2 Terminated
25 enrolled 10 charts
Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
Phase 2 Completed
45 enrolled 8 charts
A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer
Phase 2 Completed
207 enrolled 12 charts
FAPEST
Phase 2 Completed
92 enrolled 11 charts
Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy
Phase 2 Terminated
5 enrolled 6 charts
Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer
Phase 2 Completed
22 enrolled 13 charts
Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas
Phase 2 Terminated
25 enrolled 13 charts
A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival
Phase 2 Completed
153 enrolled 16 charts
ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer
Phase 1 Completed
32 enrolled 13 charts
OSI3650
Phase 2 Terminated
6 enrolled 7 charts
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
Phase 2 Completed
27 enrolled 8 charts
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Phase 2 Completed
40 enrolled 16 charts
TART
Phase 1 Completed
12 enrolled 6 charts
A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Phase 2 Completed
467 enrolled 21 charts
A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.
Phase 2 Completed
90 enrolled 11 charts
Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
Phase 2 Completed
45 enrolled 18 charts
Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Phase 2 Terminated
6 enrolled 8 charts
Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)
Phase 2 Terminated
16 enrolled 9 charts
A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.
Phase 2 Completed
51 enrolled 12 charts